Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Sharabi et al., 2003
One significant finding is from the SELECT trial, which showed that long-term use of semaglutide in individuals with obesity but without diabetes led to a 20% reduction in major cardiovascular events and an average weight loss of 9.4%
This is particularly advantageous for individuals who may not obtain sufficient vitamin B12 through their regular diet
However, a sedentary lifestyle slows your metabolism and reduces the effectiveness of treatment
Choose based on your dosing needs and syringe precision
US$ 23.23
US$ 23.61
US$ 28.36
US$ 28.51
